Amyotrophic Lateral Sclerosis (ALS)VITALSNCT07454733
Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers?
A study testing Video recording and Notes Instruction in people with Amyotrophic Lateral Sclerosis (ALS), run by Trustees of Dartmouth College at 7 sites in United States.
Trial summary
Amyotrophic lateral sclerosis (ALS) is a fatal, rare neurodegenerative disease affecting 30,000 people in the United States. The gold standard of care for people with ALS is multidisciplinary clinics (MDC). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Amyotrophic Lateral Sclerosis (ALS)
- What is being tested?
- Video recording and Notes Instruction
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 800 participants
- Where
- 7 sitesUnited States
- Study dates
- 12 Aug 2026to 1 Oct 2029
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Diagnosis of ALS by either El- Escorial or Gold Coast Criteria
- ≥18 years of age
- Plan to attend MDC visits for 12 months
- Speak English or Spanish
- Presence of a caregiver (defined as someone who assists with care) who is also participating in the VITALS trial
- Projected life expectancy of at least 12 months as determined by the site investigator.
Show all 9Show fewer
- Agree to their identified role as a caregiver of a patient with ALS participating in the VITALS trial;
- Speak English or Spanish;
- ≥18 years of age.
Who cannot join
- Unable or unwilling to provide informed consent or follow study procedures
- Significant cognitive impairment, clinical dementia, or unstable psychiatric illness (including, but not limited to, psychosis, active suicidal ideation, suicide attempt, or untreated major depression) as determined by the site investigator
- Current pregnancy based on participant self-report;
- Unable to access the internet;
- Do not have access to a personal or shared email and are not interested in creating a personal or shared email;
- Do not wish to create a patient portal account, if they do not already have one;
Show all 14Show fewer
- Uncorrected hearing or visual impairment that would impair the ability to view video recordings;
- Incarcerated.
- Unable or unwilling to provide consent or follow study procedures;
- Unable to access the internet;
- Do not have access to a personal or shared email and are not interested in creating a personal or shared email;
- Uncorrected hearing or visual impairment;
- Professional caregiver for the patient;
- Incarcerated.
Trial locations and contacts
7 sites in 1 country. Contact the study team or a site near you to ask about taking part.
7 sites in 1 country
United States7 sites, 7 recruiting
- Not yet recruiting
Massachusetts General Hospital
Boston, Massachusetts, 021114
Suma Babu, MD, 617-726-2000, sbabu@mgh.harvard.edu
Suma Babu, MD
- Not yet recruiting
Penn State Health Milton S. Hersey Medical Center
Hershey, Pennsylvania, 17033
Zachary Simmons, MD, 717-531-1377, zsimmons@pennstatehealth.psu.edu
Zachary Simmons, MD
- Not yet recruiting
Mayo Clinic Jacksonville
Jacksonville, Florida, 32224
Björn Oskarsson, MD, 904-953-2903, oskarsson.bjorn@mayo.edu
Björn Oskarsson, MD
- Recruiting
Dartmouth-Hitchcock Health
Lebanon, New Hampshire, 03756
Mark Garret, MD, 855-644-6387, Mark.A.Garret@hitchcock.org
Mark Garret, MD
- Not yet recruiting
University of Wisconsin Health
Madison, Wisconsin, 53792
Collin Kreple, MD, 608-263-5442, kreple@neurology.wisc.edu
Collin Kreple, MD
- Not yet recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213
Tawfiq Al Lahham, MD, allahhamt2@upmc.edu
Tawfiq Al Lahham, MD
- Not yet recruiting
Mayo Clinic Scottsdale
Scottsdale, Arizona, 85259
Stephen Johnson, MD, 480-301-8000, Johnson.Stephen2@mayo.edu
Stephen Johnson, MD
About this study
Official title: Comparing the Impact of Video Integration to Traditional Amyotrophic Lateral Sclerosis Visit Communication on Patient and Caregiver Quality of Life
Amyotrophic lateral sclerosis (ALS) is a fatal, rare neurodegenerative disease affecting 30,000 people in the United States. The gold standard of care for people with ALS is multidisciplinary clinics (MDC). In these multidisciplinary clinics, which occur every 3 to 4 months, people with ALS see up to 12 different healthcare providers (e.g., speech therapy, physical therapy, the ALS doctor). These clinics can last from three to five hours, and across these three to five hours people with ALS and their caregivers receive a lot of information that is critical to the care and quality of life for people with ALS. However, this information can be difficult to remember given the large amount of information that is conveyed. The current standard for providing take-home information about the visit is to provide patients with a written after-visit summary and access to their doctor's notes about the visit, typically through the patient portal. This study tests whether providing participants with video recordings of their MDC visits improves their quality of life and the quality of life of their caregivers. The study will enroll 400 pairs of people with ALS and their caregivers from eight different sites in the United States. Half of the participants in the study will receive their after-visit summary notes (the NOTES condition) and the other half of the participants will receive both their summary notes, but will also receive video recordings of their MDC visits that they can watch on their own at home (the VIDEO condition). The study will last for 12 months, with participants receiving NOTES or VIDEO at each of their regularly-scheduled MDCs during the 12 months. The study will test whether caregiver and patient participants in the VIDEO condition experience better quality of life than those in the NOTES condition at 1 month, 6 months, and 12 months from study enrollment. The results of this study will help determine what is the most effective approach to communicating MDC information to people with ALS and their caregivers.
Read the detailed description
BACKGROUND AND SIGNIFICANCE
Amyotrophic lateral sclerosis (ALS) is a fatal, rare neurodegenerative disease affecting 30,000 people in the United States. People with ALS (pwALS) and their caregivers, attend 3 - 5 hour long multidisciplinary clinics (MDC) every 3 months where they meet with up to 12 specialists. The goal of treatment is to maintain pwALS quality of life (QOL). Optimal information from MDCs is necessary for the intensive at-home management which gets more complex as ALS progresses. Yet 40% of recommendations are forgotten by pwALS negatively impacting QOL, while caregivers report information deficits increasing caregiving burden. Patient portal access to MDC notes is standard, and can improve recall and health outcomes, yet concerns exist about their layout, comprehensiveness and challenges for people with low health literacy. An underutilized strategy to share MDC information is video recording. Systematic reviews find recordings improve health outcomes, and the use of video in an ALS context may be particularly helpful given complicated at-home management. The study will determine what is the most effective approach to communicating MDC information to facilitate optimal delivery of care for pwALS and their caregivers
STUDY AIMS
Aim 1. Assess the comparative effectiveness of written MDC visit information provided to pwALS and their caregivers via the patient portal (NOTES) versus NOTES plus visit video recording (VIDEO) on patient and caregiver quality of life.
Aim 2. Determine whether patient and caregiver health literacy and rapid ALS disease progression are modifying factors on the comparative effectiveness of NOTES versus VIDEO on primary outcomes.
Aim 3. Identify system and patient-level factors that impact the implementation and use of multimodal strategies of MDC information exchange by a diverse sample of pwALS, caregivers, clinicians and health system leaders.
Hypothesis (Main Effect): Compared to those receiving NOTES, pwALS randomized to also receive routine VIDEO recordings of their MDC visit will report better QOL via improved care-management (i.e., treatment adherence), self-management ability, satisfaction with communication and reduced healthcare utilization at 12 months; there will be larger relative benefits for pwALS, and caregivers, with low health literacy and rapid disease progression. The investigators also hypothesize that compared to NOTES alone, caregivers in the VIDEO arm will report better QOL, improved preparedness and less burden at 12 months.
STUDY DESCRIPTION
Overall study design
This study is a multisite, two-arm, parallel group, patient-randomized, controlled, comparative effectiveness trial with 12-month follow-up. Adopting a Hybrid Type 1 design, the investigators will also examine implementation barriers and facilitators using interviews guided by the Consolidated Framework for Implementation Research Framework 2.0.
Comparators
Comparator 1 (NOTES): After the initial MDC study staff will provide a 15-minute training to orient participants to the portal and how to access visit notes.
Comparator 2 (VIDEO): All MDC visits will be video-recorded over 12 months, using HealthPAL, an NIH-funded HIPAA-compliant personal health library developed by PI Barr. Participants in the VIDEO arm will receive orientation to the patient portal and HealthPAL.
Following each scheduled MDC, pwALS and caregivers in both groups will receive emails reminding them to watch the visit video recording and/or review their note: 1) within 48 hours of the visit to remind them of the visit discussion and self-management tasks they may have; and 2) 3 days before their next MDC visit to prepare for their next MDC visit.
Study Population
The study recruit 400 patient and caregiver pairs (400 pwALS and their 400 caregivers) from eight MDC sites (∼50 pairs per site): Dartmouth Health (Lebanon, NH), Massachusetts General Hospital (Boston, MA), Mayo Clinics (Scottsdale, AZ, and Jacksonville, FL), Penn State Health (Hershey, PA), University of Pittsburgh Medical Center (Pittsburgh, PA), University of Wisconsin (Madison, WI) and Virginia Commonwealth University (Richmond, VA). The study will include pwALS, age ≥18 years, who plan to attend MDC visits for 12-months, speak English or Spanish, have ≥12 months projected survival, and internet access and their primary caregivers (family member or friend), ≥18 years who attends MDC visits or assist with their care.
Outcomes
Primary outcomes: For people with ALS, the total score on the ALSAQ-40 (a self report survey measure of quality of life for people with ALS) is the primary outcome. For caregivers, the total score on the PROMIS-10 (a self report survey measure of quality of life); Secondary outcomes include exercise adherence, medication adherence, adherence to MDC recommendations, self-management ability, patient satisfaction with communication, caregiver visit engagement, preparedness for caregiving, and caregiver burden. Exploratory outcomes include healthcare utilization.
Timeframe
Twelve-month follow-up for all outcomes.
- Conditions
- Amyotrophic Lateral Sclerosis (ALS)
- Being tested
- Video recording, Notes Instruction
- Keywords
- amyotrophic lateral sclerosis (ALS), Open Notes, Open Recordings, video recording, after-visit summaries
- Medical subject headings
- Amyotrophic Lateral Sclerosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Video recordingBehavioural
We will video record participants' multidisciplinary clinic (MDC) visits for 12 months. Participants will access the videos in HealthPAL, an NIH-funded, HIPAA-compliant personal health library developed with older adults and caregivers, available in Spanish and English. Each specialist visited with during the MDC will have a 'chapter' in HealthPAL that can be reviewed online at home by participants. Participants will receive orientation and training on both their patient portal and HealthPAL, including how to review and share their recordings using a take-home manual (an instructions video is also available in HealthPAL).
Notes InstructionBehavioural
Participants will be given instruction on how to view their after-visit summaries and doctors' notes in their patient portal, as well as how to give other trusted family members or friends access to their visit notes.
| Study group | Role | What they receive |
|---|---|---|
| VIDEO | Experimental | Participants in this arm of the study will have their multidisciplinary clinic visits video recorded and they will be able to access those video recordings on their own at home. They will also be able to access their doctor's notes and after visit summaries through their patient portal. Receives: Behavioral: Video recording; Behavioral: Notes Instruction |
| NOTES | Active comparator | Participants in this arm of the study will have their standard access to their doctor's notes and after visit summaries through their patient portal. They will also be provided with training on how to access and share access to their patient portal notes. Receives: Behavioral: Notes Instruction |
What is being measured
The primary outcome is the main question the study is designed to answer.
For Caregiver Participants: the total score on the PROMIS-10 self report survey
The Patient-Reported Outcomes Measurement Information System-10 (PROMIS-10) is a self-report measure of quality of life. The PROMIS-10 will be administered to caregivers via a secure online survey. We will analyze the total score on the PROMIS-10 as the primary outcome for caregiver participants.
Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.
For Patient Participants: The total score on the ALSAQ-40 self report survey.
The Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) is a self-report measure of quality of life for people with ALS. The ALSAQ-40 will be administered via a secure online survey.
Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.
Secondary outcomes (8)
Total Score on the Patient Activation Measure Short Form (PAM-SF)
The PAM-SF is a self-reported measure of self-management ability. It will be administered to participants with ALS via a secure online survey.
Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.
Total Score on the Exercise Adherence Rating Scale (EARS)
The EARS is a self-report measure of exercise adherence. It will be administered to participants with ALS via a secure online survey.
Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.
Total Score on the Adherence to Refills and Medications Scale (ARMS)
The ARMS is a self-report measure of medication adherence. It will be administered to participants with ALS via a secure online survey.
Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.
Total Score on the Adherence to Multidisciplinary Clinic Recommendations
Using a secure online survey, participants with ALS will indicate which of a list of possible clinic recommendations they received and the extent to which they adhered to those recommendations.
Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.
Total Score on the Interpersonal Processes of Care (IPC) Survey
The IPC is a self-report measure of satisfaction with the communication during a doctor visit. It will be administered via a secure online survey to participants with ALS.
Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.
Total Score on the Caregiver Perceptions About Communication with Clinical Team (CAPACITY) Survey
CAPACITY is a self-report measure of satisfaction with the communication during a doctor visit. It will be administered via a secure online survey to caregivers attending multidisciplinary clinic visits with the patient participants.
Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.
Total Score on the Preparedness for Caregiving Scale
The Preparedness for Caregiving Scale is a self-report measure, completed by the caregiver, of the caregiver's self-perceived readiness to provide care across different domains (e.g., physical, emotional). It will be administered to caregivers via a secure online survey.
Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.
Total Score on the Burden Scale for Family Caregivers - Short Form (BSFC)
The BSFC is a self-report measure of caregiver burden. It will be administered via a secure online survey to participant caregivers.
Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Mar 2026
- Study start12 Aug 2026
- Primary completion1 Sep 2029 (estimated)
- Study completion1 Oct 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Amyotrophic Lateral Sclerosis (ALS)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 800 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Trustees of Dartmouth College
- Sponsor type
- University, hospital or other
- Collaborators
- Patient-Centered Outcomes Research Institute, Massachusetts General Hospital, Dartmouth-Hitchcock Medical Center, University of Pittsburgh Medical Center, Penn State Health Milton S Hershey Medical Center, University of Wisconsin, Madison, Mayo Clinic
- Responsible party
- Principal investigator, Paul J. Barr, Trustees of Dartmouth College
- Investigators
- Paul J Barr, PhD, Principal investigator, Dartmouth CollegeSuma Babu, MD, Principal investigator, Massachusetts General Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07454733
- Sponsor's protocol ID
- RD-2024C2-40039
- Acronym
- VITALS
- Status last verified
- Oct 2026
- First submitted
- 25 Feb 2026
- Last updated
- 8 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Deidentified non-video data that will be shared include demographic data (e.g., age, gender, language, race, ethnicity, income); information on use of the patient portal and video recordings; researcher field notes (e.g., if a caregiver is present at a visit, whether the visit was telehealth or in-person); participant-reported survey responses (e.g., assessments measuring cognitive function, health literacy, quality of life, adherence, self-management ability, caregiver burden, caregiver preparedness). We will also share raw video recordings of the participants' multidisciplinary clinic visits. Raw video recordings will not be accompanied by personal identifying information, but they will not be stripped of any visual or auditory features that could potentially identify an individual.